Gyre Therapeutics – A biotechnology company focused on organ fibrosis and inflammatory diseases

Welcome to Gyre Therapeutics

We are a biotechnology company focused on organ fibrosis and inflammatory diseases. Learn more

Our Science and Pipeline

Gyre Therapeutics to Participate in Upcoming September Investor Conferences

Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update

Gyre Therapeutics Appoints Three New Members to its Board of Directors